Peer-reviewed Publications

14. Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment.
Babic I., Gorak A., Engel M., Sellers D., Else P., Osborne AL., Pai N., Huang XF., Nealon J., Weston-Green K, 2018. Journal of Psychopharmacology. doi: 10.1177/0269881118756061
Details – PublisherPubMED
13. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer U., Vine K.L., Puri P., Engel M., Belfiore L., Fildes K., Batterham M., Lochhead A. and Aghmesheh M., 2017. Cell Communication and Signalling. doi: 10.1186/s12964-017-0164-3
12. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease.
Balez R., Steiner N., Engel M., Sanz Muñoz S., Lum JS., Wu Y., Wang D., Vallotton P., Sachdev P., O’Connor M., Sidhu K., Münch G., Ooi L., 2016. Scientific Reports. doi: 10.1038/srep31450
11. Unmasking the true identity in neuron differentiation
Engel, M., 2016. Journal of Neuroscience Methods. doi: 10.1016/j.jneumeth.2016.06.022
Details – PublisherPubMED
10. Molecular evidence of synaptic pathology in the CA1 region in schizophrenia.
Matosin N., Fernandez F., Lum J., Engel M., Andrews J., Gassen N., Wagner K., Schmidt K., Newell K., 2016. NPJ Schizophrenia. doi: 10.1038/npjschz.2016.22
9. Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research. 
Engel, M., Do-Ha, D., Sanz-Muñoz, S., Ooi, L., 2016. Cellular and Molecular Life Sciences. doi: 10.1007/s00018-016-2265-3
Details – PublisherPubMED
 7 & 8 mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel, M., Snikeris, P., Matosin N, Newell, K.A., Huang, X.-F., Frank, E., 2016. Psychopharmacology (Berl.). doi: 10.1007/s00213-016-4230-0 & Erratum
Details – Publisher – PubMED
 6. Metabotropic glutamate receptor 5 and its trafficking molecules, Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.
Matosin N, Fernandez-Enright F, Lum JS, Andrews JL, Engel M, Huang XF, Newell KA. Schizophrenia Research. 2015. 166(1-3): 212-218. doi: 10.1016/j.schres.2015.05.001
Publisher – PubMED
5. Growth-factor dependent expression of the translationally controlled tumour protein TCTP is regulated through the PI3-K/Akt/mTORC1 signalling pathway. 
Bommer UA, Iadevaia V, Chen J, Knoch B, Engel M, Proud CG. Cell Signal. 2015 Apr 30. pii: S0898-6568(15)00145-X. doi: 10.1016/j.cellsig.2015.04.011.
Publisher PubMED
4. Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation. 
Matosin N, Fernandez-Enright F, Fung SJ, Lum JS, Engel M, Andrews JL, Huang XF, Weickert CS, Newell KA. Acta Neuropathol. 2015 Mar 17.
Details Publisher PubMED
3. Neuregulin 1 prevents phencyclidine-induced behavioral impairments and disruptions to GABAergic signaling in mice. 
Engel M, Snikeris P, Jenner A, Karl T, Huang X, Frank E. Int J Neuropsychopharmacol. 2014 Dec 25. pii: pyu114. doi: 10.1093/ijnp/pyu114.
2. Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture. 
Matosin N, Frank E, Engel M, Lum JS, Newell KA. Dis Model Mech. 2014 Feb;7(2):171-3. doi: 10.1242/dmm.015123.
1. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway. 
Deng C, Pan B, Engel M, Huang XF. Psychopharmacology (Berl). 2013 Mar;226(2):201-15. doi: 10.1007/s00213-013-3003-2. Review.

PubMed listing | Google scholar listing
View my publications button for Martin Engel

Editorials and Articles

Positives in negative results: when finding ‘nothing’ means something. The Conversation, 25. September 2014.

Print Friendly, PDF & Email